Elos Medtech AB announces that the release of the Year-end report for 2017 is moved from February 22nd to February 19th.
Elos Medtech is one of the leading development and production partners for medical technology products and components in the world, such as dental and orthopedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and the US. Customers are internationally active medical technology companies.
Elos Medtech employs more than 500 people worldwide and generates revenue that exceeds MSEK 550. Elos Medtech has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.
Gothenburg, December 6, 2017
Elos Medtech AB (publ)
For further information, please contact: Jan Wahlström, CEO, 46 70 212 18 89, e-mail: [email protected]
Christian Bergaust, CFO, 46 70 293 50 40, e-mail: christia[email protected]
For additional information about the Elos Medtech Group, visit www.elosmedtech.com
This information is information that Elos Medtech AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on December 6, 2017, at 08:00 (CET).
Powered by WPeMatico